As both WNV and USUV-infected in vitro BBBs showed comparable measures of barrier function to mock, the reduction in MMP-9 and CCL2 concentrations was therefore not sufficient to induce a direct, detectable decrease in permeability of the barrier as a response to infection. The gene discussed is MMP9; the disease is infection.